Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

MICROPHASE CLINICAL LABORATORY

NPI: 1619039047 · HUNTSVILLE, AL 35803 · Clinical Medical Laboratory · NPI assigned 12/14/2006

$483K
Total Medicaid Paid
26,855
Total Claims
24,724
Beneficiaries
18
Codes Billed
2018-01
First Month
2024-11
Last Month

Provider Details

Authorized OfficialWOODY, WALTER (PRESIDENT)
NPI Enumeration Date12/14/2006

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 2,527 $31K
2019 3,774 $46K
2020 4,460 $58K
2021 6,295 $89K
2022 6,563 $78K
2023 1,531 $86K
2024 1,705 $94K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 746 699 $146K
87184 2,155 1,752 $97K
87070 7,512 7,119 $70K
87077 7,794 7,130 $67K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 1,180 1,041 $23K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 898 790 $22K
87075 1,678 1,599 $14K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 253 222 $13K
87147 1,437 1,353 $8K
87205 1,033 978 $5K
87071 696 666 $4K
87073 660 628 $4K
87088 209 174 $2K
87086 Culture, bacterial; quantitative colony count, urine 231 211 $2K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 40 39 $2K
87185 256 248 $1K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 38 37 $1K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 39 38 $990.70